Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

ARIAD reports lower Q4 net loss, provides guidance for 2015

ARIAD Pharmaceuticals, Inc., an oncology company, has reported that net loss for the fourth quarter ended December 31, 2014 was $5.75 million, or $0.03 loss per share, compared to a net loss of $74.16 million, or $0.40 loss per share, for the same quarter ended December 31, 2013. For 2015, the company expects net product revenues from sales of Iclusig to be in the range of $130 million to $140 million...more >>

NGM and Merck collaborate to develop and commercialize new biologic therapies

NGM Biopharmaceuticals, Inc. and Merck have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies...more >>

Rigel and Bristol-Myers collaborate to develop cancer immunotherapies

Rigel Pharmaceuticals, Inc. and Bristol-Myers Squibb Company have entered into a collaboration agreement for the discovery, development and commercialization of cancer immunotherapies based on Rigel's portfolio of small molecule TGF beta receptor kinase inhibitors...more >>

Genmab enters into DuoBody technology agreement with BioNovion

Genmab A/S, a biotechnology company, has entered a co-development and commercialization agreement with BioNovion to evaluate a number of DuoBody product candidates targeting immune checkpoints...more >>